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We describe a 60-year old man with the history of radical correction of the Tetralogy of
Fallot (TOF) in the year 1964. This patient has had a long lasting decompensation of a
severe right heart failure with ascites and pulmonary hypertension. On echocardiography
he had residual mild pulmonary stenosis (PS) and severe pulmonary and tricuspid
regurgitation (TR), moderate aortic and mitral regurgitation. He also had residual ven-
tricular septal defect (VSD) and severe pulmonary hypertension with the maximal gradient
on TR 83 mmHg. He was considered unoperable by his cardiologist, however patient
decided to undergo a high-risk operation. The operation comprised pulmonary and aortic
valve replacement with bioprosthesis, mitral and tricuspid repair, closure of ventricular
septal defect, bilateral MAZE and volume reduction of both atria. After a very complicated
postoperative course with multiorgan failure he recovered and was discharged home 2
months after operation. The NYHA class improved from IV before operation to II. Twenty
months after this operation he experienced infective endocarditis with a leak on the aortic
bioprosthesis. He was reoperated with reimplantation of a new aortic bioprosthesis and
with a very complicated postoperative course. Sildenafil was added to his therapy due to
the persistent severe pulmonary hypertension. He survived and was discharged home.
The presented unique high-risk complex reoperation of a congenital heart disease with
pulmonary hypertension can be performed only by a very experienced cardiosurgical and
cardio-anesthesiological team with a high level of the early and late postoperative care.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
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Table 2 – Catheterization before operation (right and left
catheterization, oxymetry, selective coronarography).
Qp (pulmonary flow) 9.7 l/min
Qs (systemic flow) 4.8 l/min





PS: peak gradient 25 mmHg
Coronarography No coronary stenosis
Qp, pulmonary flow; Qs, systemic flow; WU, Wood units; PVR,
pulmonary vascular resistance; PAP, pulmonary arterial pressure;
PAPm, mean pulmonary arterial pressure; PCW, pulmonary wedge
pressure; PS, pulmonary stenosis.
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At present, the survival of children born with a congenital
heart disease (CHD) into adulthood exceeds 85% [1–3]. The
reason is probably the improved intensive care and cardiac
surgery in newborns and babies with critical CHD. However,
even after successful operation in childhood there is a risk of
residual findings. Some of the residual findings (sequelae) are
obligatory, e.g. degeneration of homografts or pulmonary
regurgitation after the excision or decision of pulmonary
valve. Other residua (e.g. residual defects) are due to the
insufficient surgical technique, especially in 60th or 70th.
Besides that, we can find acquired valve disease in a patient
originally treated for CHD. Even severe residual lesions may
be clinically silent for a long time. At the time of limiting
symptoms the risk of the operation may be already very high.
According to our experience, the most important risk factors
of mortality in reoperations of adults with CHD are NYHA
class III and IV, cyanosis and dysfunction of the right or left
ventricle [4].
Tetralogy of Fallot (TOF) is one of the most common
cyanotic CHD, it represents 4–10% of all CHD [2,3]. The long-
term survival after the corrective surgery in childhood is very
good. Approximately 90% of those, who survived operation,
are still alive after 20–30 years [5–7]. The most common
residual finding in TOF is pulmonary regurgitation, less
common is pulmonary stenosis or residual ventricular septal
defect (VSD) [2,3,8].
We describe a unique case of two reoperations in an older
patient with TOF, who was considered inoperable because of
the severe state with long lasting severe right heart failure,
pulmonary hypertension and because of the extent of the
surgery. We did not find any similar case report in the
literature.
1.1. Description of the case
Our patient was born in 1950 with Tetralogy of Fallot. He had
radical correction in 14 years, in the year 1964, the operation
was performed by professor Navra´til in Brno, Czechoslovakia.
Residual VSD was found in 1970, but reoperation was notTable 1 – Comparison of the echocardiographic examinations




RV 45 mm (PLAX)
57 mm (A4CH)
RV anterior wall 15 mm
RVEF 40%
LA 81 75 mm
RA 94 81 mm
TR gradient (max/mean) 83/40 mmHg
VCI 41 mm
LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection f
atrium; RA, right atrium; RV, right ventricle; LV, left ventricle; PLAX, parperformed because of the high operative risk and small
patient’s complaints. The reoperation was offered to our
patient again in 2002, but he refused. In 2006 he was
repeatedly hospitalized because of severe right heart decom-
pensation with repeated ascites evacuation. He had persis-
tent atrial fibrillation and non-sustained ventricular
tachycardias (VT). He was referred to Hospital Na Homolce
for implantable cardioverter-defibrillator (ICD) implantation,
which was not performed because of the hypocalemia as the
possible reason of VT. We performed a thorough reevaluation
of all the residual findings and proposed a possibility of a
high-risk reoperation.
We performed echocardiography (Table 1) and catheteriza-
tion (Table 2). We found a high Doppler CW gradient
(83/40 mmHg) on a massive tricuspid regurgitation (TR) dur-
ing the first examination. This finding could imply irreversi-
ble pulmonary hypertension and inoperable state. However,
the gradient on TR was increased by the residual pulmonary
stenosis with the systolic gradient assessed by Doppler
46 mmHg. We also found moderate pulmonary, aortic and
mitral regurgitations. The aortic regurgitation was caused by
degenerative changes of the leaflets, vena contracta was
5 mm, pressure half time 366 ms and width of the jet was
15 mm¼65% of the left ventricular outflow tract. Moderate
mitral regurgitation was caused by annular dilatation to
46 mm and a small prolaps of the anterior leaflet, venabefore and after operation.
ECHO before operation ECHO after operation
7.4.2010 10.1.2011
53/42 mm 60/44 mm
45% 55–60%
45 mm (PLAX) 46 mm (PLAX)
57 mm (A4CH) 39 mm (A4CH)
RV anterior wall 14 mm
40% 40–45%
100 60 mm 6377 mm
93 91 mm 61 mm in the long axis
55/26 mmHg 34/ 23 mmHg
41 mm 26/14 mm
raction; VCI, vena cava inferior; TR, tricuspid regurgitation; LA, left
asternal long axis projection; A4CH, apical four-chamber view.
Fig. 3 – Echocardiography, apical four-chamber view (A4C),
severe tricuspid regurgitation, vena contracta 12.3 mm.
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 2 9 5 – e 2 9 9 e297contracta was 5mm. Severe tricuspid regurgitation (Figs. 3 and
4) was a consequence of tricuspid annulus dilatation to 50mm.
The left ventricular end-diastolic diameter (LVEDD) was at
the upper level (56 mm¼27 mm/m2) with a mild systolic
dysfunction. The right ventricle had severe hypertrophy of
the wall (14–15 mm) and was dilated to 57 mm with moder-
ately impaired systolic function (Tables 1 and 2). Both atria
were severely dilated (left atrium 8175 mm, right atrium
9481 mm).
On the catheterization we found moderate pulmonary
hypertension with the pulmonary arterial pressure (PAP) 62/
22; mean 34 mmHg, wedge pressure (PCW) 19 mmHg, pul-
monary arterial resistance 1, 5 Wood units, mild pulmonary
stenosis with the peak gradient 25 mmHg. After epoprostenol
administration (6 ng/kg/min) there was a significant reduc-
tion of PAP to 37/23; mean 26 mmHg. The pulmonary to
systemic flow ratio (Qp/Qs) measured by oxymetry was 2:1
(Table 2).Fig. 1 – Echocardiography, long axis parasternal projection,
ventricular septal defect in CFM: left-to-right shunt from left
to right ventricle.
Fig. 2 – Echocardiography, short axis parasternal projection,
CFM shows moderate pulmonary regurgitation.
Fig. 4 – CW Doppler, high gradient on tricuspid regurgitation
before operation.The definitive diagnosis was hemodynamically significant
residual VSD with Qp/Qs 2:1 (Fig. 1), severe tricuspid regur-
gitation, mild pulmonary stenosis, moderate pulmonary,
aortic and mitral regurgitation and moderate, mainly post-
capillary pulmonary hypertension (Fig. 2).
Our patient was cachectic with large ascites, hepatosple-
nomegaly, renal insufficiency, diabetes mellitus, chronic
obstructive lung disease (heavy smoker) and had the history
of bleeding from the duodenal ulcer.
The risk of operation was extremely high, logistic Euroscore
37%. However, due to the severe complaints and poor quality
of life our patient decided to undergo high-risk operation.
He was operated on 8.4.2010 at the department of Cardiac
surgery in Hospital Na Homolce. Aortic valve had a prolaps of
the left coronary cusp and severe degeneration of the non-
coronary cusp and was replaced by a bioprosthesis of the
diameter 27 mm. The totally degenerated pulmonary was
removed and replaced by a bioprosthesis of the diameter
27 mm. It was implanted supraannulary because of the
calcification of the right ventricular outflow tract (RVOT).
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 2 9 5 – e 2 9 9e298The dilated mitral annulus was repaired by annuloplastic ring
of the diameter 34 mm. Afterwards tricuspid annuloplastic
ring was given. The residual ventricular septal defect with the
diameter of 8 mm was closed by xenopericardial patch.
Furthermore right and left-sided MAZE (cryoablation) and
volume reduction of both atria were performed. The cardio-
pulmonary bypass time took 368 min and aortic cross clamp
duration was 293 min. At the end of the operation levosi-
mendan and vasopressors were given prophylactically and
continuous arterio-venous hemofiltration in citrate was
started because of oliguria. The postoperative course was
complicated by multiorgan failure, sepsis and bronchopneu-
monia. Since 14.5.2010 the patient was hospitalized at the
Intensive and metabolic care unit in the Department of
Medicine in Hospital Na Homolce with complex and intensive
nutrition and rehabilitation care. Two months after the
operation our patient was able to be discharged home.
In the first half of the year 2011 he was feeling well, without
signs of heart failure, and with improved exertion tolerance,
he was in NYHA class II. He had sinus rhythm on ECG and
good function of both bioprosthesis and repaired valves, no
residual ventricular shunt and mild pulmonary hypertension
with the calculated PAP systolic/mean 40/29 mmHg (Fig. 5).
In December 2011 the patient was readmitted to our
hospital with infective endocarditis on the aortic bioprosth-
esis with severe aortic regurgitation due to the leak on the
bioprosthesis. The etiologic agent was Enterococcus faecalis,
most probably from the residual sacral decubitus. He was
septic, with oliguric renal failure, severe cardiac decompen-
sation, severe pulmonary hypertension (from echocardio-
graphic calculation systolic PAP 70 mmHg, mean PAP
40 mmHg), NYHA IV. He had no mitral regurgitation and only
mild tricuspid regurgitation. On ECG there was a sinus
rhythm without atrial fibrillation recurrence. Because of the
critical state, patient was not catheterized, nor tested for
vasodilatation therapy.
On the 23.12.2011 the patient was reoperated in a very severe
state with reimplantation of a new aortic bioprosthesis.Fig. 5 – Echocardiography: trace tricuspid regurgitation on
CFM with decreased CW Doppler gradient after operation.
The gradient 34/23 mmHg reflects PAP 40/29 mmHg
(systolic/mean).Postoperatively levosimendan and Novoseven (recombinant
coagulation factor VII.) were given. Because of the persistent
severe pulmonary hypertension (invasively measured PAP was
79/25, mean 45mmHg) iloprost and sildenafil were added. He
had continuous veno-venous dialysis in citrate. Later he was
transmitted from Cardiac surgery to Intensive care unit in
Medicine department. He was able to leave hospital on
10.2.2012 with ambulatory care of the sacral decubitus.2. Discussion
Most adults with TOF have undergone radical surgical correc-
tion in childhood. Only rarely we can meet unoperated adult
with TOF or a patient with palliative shunt only [10]. The
long-term prognosis is good, 92% of those, who survived
operation of TOF in childhood, reach adulthood in our
country [5].
The first radical correction of TOF in the world was
performed on cardio-pulmonary bypass by Lillehei in 1954
and Kirklin in 1955. The first radical correction of TOF in
Czech Republic (formerly Czechoslovakia) was performed by
Jan Navra´til in Brno in 1961. Our patient was in fact one of the
first radically operated patients in our country. At the time of
the first operation he was rather old – 14 years. The residua
and sequeale of the operations performed in 60th and 70th
are relatively frequent. If they do not course any severe
complaints, they may be easily overlooked and may not be
solved at the proper time.
Pulmonary regurgitation (PR) is the most common residual
finding after radical correction of TOF. The pulmonary valve is
often incised, sometimes even excised and in the case of
hypoplastic annulus the transannular patch may be used [5].
PR used to be considered for benign lesion, however there is
an association between the severity of PR, dilatation of the
right ventricle, prolongation of QRS with right bundle branch
block on the ECG over 180 ms and sudden arrhythmic death
[11]. Dilatation and dysfunction of the right ventricle are
reversible to certain extent only. Nowadays there is a trend
towards earlier correction of the PR in TOF [8,12].
Tricuspid regurgitation (TR) is a secondary lesion due to the
dilated right ventricle. If there is no organic cause, it may be
repaired, usually with annuloplasty ring.
Aortic regurgitation (AR) can be seldom found before correc-
tion of the TOF (in 2%). It may be more frequent after the
correction [9]. The cause may be in dilated annulus and aortic
root of the overriding aorta as well as due to the retraction,
perforation, fibrosis or calcification of the aortic cusps, often
due to the injury during subaortic VSD closure.
Mitral regurgitation (MR) is not typical for TOF, however we
can find it in some patients due to the dilatation of the mitral
annulus, myxomatous changes of the mitral valve and
prolaps.
Pulmonary hypertension (PH) is not a part of the TOF. TOF is
characterized by low pulmonary flow and low pulmonary
pressure before correction. Pulmonary hypertension may be a
consequence of a too large aorto-pulmonary shunt, however
this was not the case of our patient. Our patient had PH as a
result of the combination of high pulmonary flow due to
the residual VSD and a high pulmonary wedge pressure.
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regurgitations, there remained certain degree of pulmonary
vascular disease with increased trend to pulmonary vasocon-
striction, which could be seen after the second operation. It
could be partly corrected by sildenafil. All patients with CHD
and echocardiographic suspicion of PH need a thorough
examination, exclusion of pulmonary stenosis and right
heart catheterization with the assessment of pulmonary
arterial resistance (PAR) and vasodilatation testing. The
specific vasodilating therapy cannot be started in CHD only
on the basis of TR gradient. The contraindication for shunt
closure in CHD is high PAR (over 7–10 WU or higher than 2/3
of the systemic resistance) [8,13].
TOF is a CHD with the possibility of many residual findings
in the long-term follow-up. As we have shown, there may be
a dysfunction of all four heart valves besides the residual
shunts on ventricular or atrial level. The decision if to operate
VSD only or to perform a complex repair of all valves was not
easy. Our patient had more reasons for left ventricular
volume overload (AR, MR, VSD), but he had only borderline
left ventricular dilatation. In our experience it is very difficult
to assess the severity of the left-side valve regurgitations in
the presence of severe right ventricular dilatation. This is
because of the limited space in the pericardial cavity. Our
patient had severely dilated right ventricle to 57 mm. There-
fore we assumed that the AR and MR may have had
hemodynamic significance even without severe left ventri-
cular dilatation. Instead of dilatation there may be increased
filling pressure of the left ventricle. That was the reason why
we decided to perform a complex repair of all valve lesions
besides VSD closure in our patient. The long-term stable
sinus rhythm has been achieved by valvular competence,
MAZE procedure and volume reduction of the atria.
In Hospital Na Homolce we performed 12 operations on 3–4
heart valves in patients with CHD in the years 2005–2010 [4].
Three of them had TOF. The operation of 3 or 4 valves
represented 2.68% of all our operations of adults with CHD,
one patient from this group did not survive [4].
The hospital mortality in more than 500 operated adults
with CHD in Hospital Na Homolce was 1.54% [4]. This is
comparable to other world high volume centers. Good results
are dependent on experience, team co-operation and excel-
lent postoperative care. Even with these good results the
decision concerning operation of our patient was difficult
because of the severe state, older age and extent of the
surgery. The positive approach of our patient was important.
We did not find similar case in the literature.3. Conclusion
The operation of all four heart valves is rare and in connection
with complex CHD unique. This high-risk operation was per-
formed in a severely ill patient with severe heart failure andpulmonary hypertension. The operation was successful only due
to very experienced surgical and cardio-anesthesiological team
and high level of postoperative care. The results of reoperations
in adults with CHD are good in specialized, high volume centers.
The question stated in the title could be answered ‘‘yes’’, it
is possible.
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